Skip to main content
Erschienen in: Pediatric Nephrology 12/2007

01.12.2007 | Original Article

Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis

verfasst von: Nicholas J. A. Webb, Malcolm G. Coulthard, Richard S. Trompeter, Margaret M. Fitzpatrick, Suzanne Stephens, Jan Dudley, Heather Maxwell, Simon Waller, Graham C. Smith, Alan R. Watson, David A. Hughes, Brian G. Keevil, Janice S. Ellis

Erschienen in: Pediatric Nephrology | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

The aims of this study were (1) to ascertain ciclosporin C2 levels currently being achieved in children with steroid-sensitive nephrotic syndrome (SSNS) and renal transplants (RTs), (2) to determine the feasibility of the use of finger-prick samples for the measurement of ciclosporin levels, and (3) to identify any correlation between hypertrichosis or gingival overgrowth (GO) and level of ciclosporin 2 h post-dose (C2). Seventy-two children (39 with SSNS, 33 with RT) participated. Ciclosporin 12 h trough (C12) and C2 levels were measured in venous and finger-prick samples by high-performance liquid chromatography tandem mass spectroscopy. Photographs of the teeth and back were taken for assessment of GO and hypertrichosis. Mean (±SD) C2 levels in the SSNS and RT groups were 512 (±181) μg/l and 471 (±229) μg/l. There was a highly significant relationship between venous and finger-prick ciclosporin levels (r2 = 0.96, P < 0.0001). Fourteen children had severe GO. There was a small, though statistically significant, impact of ciclosporin level on GO (C2 r2 = 0.12, P = 0.003 and C12 r2 = 0.06, P = 0.038) but no correlation with dose (milligrammes per kilogramme per day or milligrammes per square metre per day) or duration. Seventeen children had moderate or severe hypertrichosis, this being more common in children of South Asian ethnicity (P < 0.0001). There was no correlation between ciclosporin exposure or duration and hypertrichosis. Finger-prick blood sampling may serve as a practical alternative to venepuncture in children receiving ciclosporin.
Literatur
1.
Zurück zum Zitat Nashan B, Bock A, Bosmans J-L, Budde K, de Fijter H, Jaques B, Johnston A, Luck R, Midtvedt K, Pallardo LM, Ready A, Salame E, Salizzoni M, Suarez F, Thervet E (2005) Use of Neoral C2 monitoring: a European consensus. Transpl Int 18:768–778CrossRef Nashan B, Bock A, Bosmans J-L, Budde K, de Fijter H, Jaques B, Johnston A, Luck R, Midtvedt K, Pallardo LM, Ready A, Salame E, Salizzoni M, Suarez F, Thervet E (2005) Use of Neoral C2 monitoring: a European consensus. Transpl Int 18:768–778CrossRef
2.
Zurück zum Zitat Levy GA (2001) C2 monitoring strategy for optimising ciclosporin immunosuppression from the Neoral formulation. BioDrugs 15:279–290CrossRef Levy GA (2001) C2 monitoring strategy for optimising ciclosporin immunosuppression from the Neoral formulation. BioDrugs 15:279–290CrossRef
3.
Zurück zum Zitat Buchler M, Johnston A (2005) Seeking optimal prescription of cyclosporine ME. Ther Drug Monit 27:3–6CrossRef Buchler M, Johnston A (2005) Seeking optimal prescription of cyclosporine ME. Ther Drug Monit 27:3–6CrossRef
4.
Zurück zum Zitat Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G (2005) Cyclosporine therapy monitored with abbreviated area under the curve in nephrotic syndrome. Pediatr Nephrol 20:25–29CrossRef Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G (2005) Cyclosporine therapy monitored with abbreviated area under the curve in nephrotic syndrome. Pediatr Nephrol 20:25–29CrossRef
5.
Zurück zum Zitat Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359–1360CrossRef Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359–1360CrossRef
6.
Zurück zum Zitat Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suziki K, Ito E, Waga S (2005) C1-C2 point monitoring of low-dose cyclosporin A given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Clin Nephrol 64:258–263CrossRef Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suziki K, Ito E, Waga S (2005) C1-C2 point monitoring of low-dose cyclosporin A given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Clin Nephrol 64:258–263CrossRef
7.
Zurück zum Zitat Nozu K, Iijima K, Sakaeda T, Okumura K, Nakanishi K, Yoshikawa N, Honda M, Ikeda M, Matsuo M (2005) Cyclosporin A absorption profiles in children with nephrotic syndrome. Pediatr Nephrol 7:910–913CrossRef Nozu K, Iijima K, Sakaeda T, Okumura K, Nakanishi K, Yoshikawa N, Honda M, Ikeda M, Matsuo M (2005) Cyclosporin A absorption profiles in children with nephrotic syndrome. Pediatr Nephrol 7:910–913CrossRef
8.
Zurück zum Zitat Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S (2005) Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 9:381–390CrossRef Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S (2005) Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 9:381–390CrossRef
9.
Zurück zum Zitat David-Neto E, Lemos FB, Furusawa EA, Schwartzman BS, Cavalcante JS, Yagyu EM, Romano P, Ianhez LE (2000) Impact of ciclosporin A pharmacokinetics on the presence of side-effects in pediatric renal transplantation. J Am Soc Nephrol 11:343–349PubMed David-Neto E, Lemos FB, Furusawa EA, Schwartzman BS, Cavalcante JS, Yagyu EM, Romano P, Ianhez LE (2000) Impact of ciclosporin A pharmacokinetics on the presence of side-effects in pediatric renal transplantation. J Am Soc Nephrol 11:343–349PubMed
10.
Zurück zum Zitat Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G (1983) Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Peridontol 10:237–246CrossRef Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G (1983) Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Peridontol 10:237–246CrossRef
11.
Zurück zum Zitat Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR (1995) Iatrogenic gingival overgrowth in cardiac transplantation. J Peridontol 66:742–746CrossRef Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR (1995) Iatrogenic gingival overgrowth in cardiac transplantation. J Peridontol 66:742–746CrossRef
12.
Zurück zum Zitat Ellis JS, Seymour RA, Robertson P, Butler TJ, Thomason JM (2001) Photographic scoring of gingival overgrowth. J Clin Peridontol 28:81–85CrossRef Ellis JS, Seymour RA, Robertson P, Butler TJ, Thomason JM (2001) Photographic scoring of gingival overgrowth. J Clin Peridontol 28:81–85CrossRef
13.
Zurück zum Zitat Thomason JM, Seymour RA, Rawlins MD (1992) Incidence and severity of phenytoin–induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 20:288–291CrossRef Thomason JM, Seymour RA, Rawlins MD (1992) Incidence and severity of phenytoin–induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 20:288–291CrossRef
14.
Zurück zum Zitat Thomas DW, Newcombe RG, Osborne G (2000) Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 70:552–556 Thomas DW, Newcombe RG, Osborne G (2000) Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 70:552–556
15.
Zurück zum Zitat Thomas DW, Baboolal K, Subramanian N, Newcombe RG (2001) Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Peridontol 28:706–709CrossRef Thomas DW, Baboolal K, Subramanian N, Newcombe RG (2001) Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Peridontol 28:706–709CrossRef
16.
Zurück zum Zitat Thomason JM, Seymour RA, Ellis JS (2005) Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. J Clin Peridontol 32:273–279CrossRef Thomason JM, Seymour RA, Ellis JS (2005) Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. J Clin Peridontol 32:273–279CrossRef
17.
Zurück zum Zitat Webb NJ, Roberts D, Preziosi R, Keevil BG (2005) Finger prick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Pediatr Transplant 9:729–733CrossRef Webb NJ, Roberts D, Preziosi R, Keevil BG (2005) Finger prick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Pediatr Transplant 9:729–733CrossRef
18.
Zurück zum Zitat Merton G, Jones K, Lee M, Johnston A, Holt DW (2000) Accuracy of cyclosporine measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit 22:594–598CrossRef Merton G, Jones K, Lee M, Johnston A, Holt DW (2000) Accuracy of cyclosporine measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit 22:594–598CrossRef
19.
Zurück zum Zitat Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA (2004) Patient preferences for capillary vs venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res 114:161–165CrossRef Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA (2004) Patient preferences for capillary vs venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res 114:161–165CrossRef
20.
Zurück zum Zitat Keevil BG, Tierney DP, Cooper DP, Morris MR, Machaal A, Yonan N (2002) Simultaneous and rapid analysis of ciclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application to C2 monitoring. Ther Drug Monit 24:757–767CrossRef Keevil BG, Tierney DP, Cooper DP, Morris MR, Machaal A, Yonan N (2002) Simultaneous and rapid analysis of ciclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application to C2 monitoring. Ther Drug Monit 24:757–767CrossRef
21.
Zurück zum Zitat Yonan N, Martyszuk R, Machaal A, Baynes A, Keevil BG (2006) Monitoring of cyclosporin levels in transplant recipients using self administered finger prick sampling. Clin Transplant 20:221–225CrossRef Yonan N, Martyszuk R, Machaal A, Baynes A, Keevil BG (2006) Monitoring of cyclosporin levels in transplant recipients using self administered finger prick sampling. Clin Transplant 20:221–225CrossRef
22.
Zurück zum Zitat Ferriman D, Gallwey JD (1961) Clinical measurement of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447CrossRef Ferriman D, Gallwey JD (1961) Clinical measurement of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447CrossRef
23.
Zurück zum Zitat Hollis S (1996) Analysis of method comparison studies. Ann Clin Biochem 33:1–4CrossRef Hollis S (1996) Analysis of method comparison studies. Ann Clin Biochem 33:1–4CrossRef
24.
Zurück zum Zitat Pape L, Lehnhardt A, Latta K, Ehrich JH, Offner G (2003) Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients. Clin Transplant 17:546–548CrossRef Pape L, Lehnhardt A, Latta K, Ehrich JH, Offner G (2003) Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients. Clin Transplant 17:546–548CrossRef
25.
Zurück zum Zitat Pape L, Ehrich JH, Offner G (2004) Advantages of cyclosporine A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol 19:1035–1038CrossRef Pape L, Ehrich JH, Offner G (2004) Advantages of cyclosporine A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol 19:1035–1038CrossRef
26.
Zurück zum Zitat Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Brekke IB, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomised multicentre study comparing tacrolimus with cyclosporin in renal transplantation. Pediatr Nephrol 17:141–149CrossRef Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Brekke IB, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomised multicentre study comparing tacrolimus with cyclosporin in renal transplantation. Pediatr Nephrol 17:141–149CrossRef
27.
Zurück zum Zitat Mahalati K, Belitsky P, Sketris I, West K, Panek R (1999) Neoral monitoring by simplified sparse sampling area under the concentration curve: its relationship to acute rejection and cyclosporine nephrotoxicity after kidney transplantation. Transplantation 68:55–62CrossRef Mahalati K, Belitsky P, Sketris I, West K, Panek R (1999) Neoral monitoring by simplified sparse sampling area under the concentration curve: its relationship to acute rejection and cyclosporine nephrotoxicity after kidney transplantation. Transplantation 68:55–62CrossRef
28.
Zurück zum Zitat Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J (2001) Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 12:828–833PubMed Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J (2001) Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 12:828–833PubMed
29.
Zurück zum Zitat Weber LT, Armstrong VW, Shipkova M, Feneberg R, Wiesel M, Mehls O, Zimmerhackl LB, Lellerich M, Tonshoff B, Members of the German Study Group on Pediatric Renal Transplantation (2004) Cyclosporin A absorption in pediatric renal transplant recipients predicts the risk of acute rejection. Ther Drug Monit 26:415–424CrossRef Weber LT, Armstrong VW, Shipkova M, Feneberg R, Wiesel M, Mehls O, Zimmerhackl LB, Lellerich M, Tonshoff B, Members of the German Study Group on Pediatric Renal Transplantation (2004) Cyclosporin A absorption in pediatric renal transplant recipients predicts the risk of acute rejection. Ther Drug Monit 26:415–424CrossRef
30.
Zurück zum Zitat Kyllönen LE, Salmela KT (2006) Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study. Transplantation 81:1010–1015CrossRef Kyllönen LE, Salmela KT (2006) Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study. Transplantation 81:1010–1015CrossRef
Metadaten
Titel
Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis
verfasst von
Nicholas J. A. Webb
Malcolm G. Coulthard
Richard S. Trompeter
Margaret M. Fitzpatrick
Suzanne Stephens
Jan Dudley
Heather Maxwell
Simon Waller
Graham C. Smith
Alan R. Watson
David A. Hughes
Brian G. Keevil
Janice S. Ellis
Publikationsdatum
01.12.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2007
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0586-z

Weitere Artikel der Ausgabe 12/2007

Pediatric Nephrology 12/2007 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.